US Stock MarketDetailed Quotes

CGEM Cullinan Oncology

Watchlist
  • 15.660
  • -2.400-13.29%
Close Apr 19 16:00 ET
  • 15.710
  • +0.050+0.32%
Post 16:39 ET
674.41MMarket Cap-4243P/E (TTM)

Cullinan Oncology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
44.28%190.65M
39.49%45.49M
50.52%44.8M
1.34%37.61M
92.17%62.76M
52.06%132.14M
-5.06%32.61M
61.99%29.77M
123.48%37.11M
85.86%32.66M
Selling and administrative expenses
5.73%42.49M
-5.76%10.64M
8.88%10.98M
-4.50%10.21M
31.26%10.66M
37.89%40.19M
-16.20%11.29M
77.10%10.09M
121.61%10.7M
57.51%8.12M
-General and administrative expense
5.73%42.49M
-5.76%10.64M
8.88%10.98M
-4.50%10.21M
31.26%10.66M
37.89%40.19M
-16.20%11.29M
77.10%10.09M
121.61%10.7M
57.51%8.12M
Research and development costs
61.13%148.16M
63.44%34.85M
71.85%33.82M
3.71%27.39M
112.32%52.1M
59.21%91.95M
2.12%21.32M
55.21%19.68M
124.24%26.41M
97.63%24.54M
Operating profit
-44.28%-190.65M
-39.49%-45.49M
-50.52%-44.8M
-1.34%-37.61M
-92.17%-62.76M
-94.45%-132.14M
5.06%-32.61M
-61.99%-29.77M
-123.48%-37.11M
-2,480.25%-32.66M
Net non-operating interest income expense
227.14%21.63M
75.89%5.92M
149.89%5.88M
663.56%5.32M
2,188.32%4.51M
1,285.95%6.61M
2,355.47%3.36M
1,894.07%2.35M
302.89%697K
302.04%197K
Non-operating interest income
227.14%21.63M
75.89%5.92M
149.89%5.88M
663.56%5.32M
2,188.32%4.51M
1,285.95%6.61M
2,355.47%3.36M
1,894.07%2.35M
302.89%697K
302.04%197K
Other net income (expense)
-100.07%-201K
-139.26%-117K
-260K
-99.98%69K
107K
3,460,625.00%276.84M
7,350.00%298K
3,456,900.00%276.54M
Special income (charges)
-100.16%-440K
--0
---440K
--0
----
--276.79M
--0
--0
--276.79M
----
-Less:Impairment of capital assets
--440K
--0
--440K
----
----
--0
--0
--0
----
----
-Gain on sale of business
--0
--0
--0
--0
----
--276.79M
--0
--0
--276.79M
----
Other non- operating income (expenses)
319.30%239K
-139.26%-117K
--180K
128.63%69K
--107K
812.50%57K
7,350.00%298K
----
-2,912.50%-241K
----
Income before tax
-211.83%-169.22M
-37.10%-39.69M
-42.94%-39.18M
-113.41%-32.21M
-79.12%-58.14M
324.22%151.32M
15.38%-28.95M
-50.13%-27.41M
1,560.76%240.14M
-2,387.53%-32.46M
Income tax
-133.53%-14.12M
-660.06%-14.12M
0
0
0
42.12M
-1.86M
-2.52M
66.07M
-19.57M
Net income
-242.04%-155.1M
5.63%-25.56M
-57.42%-39.18M
-118.51%-32.21M
-350.99%-58.14M
261.81%109.2M
20.81%-27.09M
-36.32%-24.89M
1,158.85%174.07M
-1,008.53%-12.89M
Net income continuous Operations
-242.04%-155.1M
5.63%-25.56M
-57.42%-39.18M
-118.51%-32.21M
-350.99%-58.14M
261.81%109.2M
20.81%-27.09M
-36.32%-24.89M
1,158.85%174.07M
-1,008.53%-12.89M
Minority interest income
3.96%-1.94M
-475.16%-1.76M
0
0
77.46%-179K
-5.43%-2.02M
81.91%-306K
90.54%-86K
-3.74%-833K
-153.32%-794K
Net income attributable to the parent company
-237.72%-153.16M
11.12%-23.8M
-57.97%-39.18M
-118.42%-32.21M
-379.10%-57.96M
269.61%111.21M
17.63%-26.78M
-42.96%-24.8M
1,218.56%174.9M
-17,182.86%-12.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-237.72%-153.16M
11.12%-23.8M
-57.97%-39.18M
-118.42%-32.21M
-379.10%-57.96M
269.61%111.21M
17.63%-26.78M
-42.96%-24.8M
1,218.56%174.9M
-17,182.86%-12.1M
Basic earnings per share
-250.00%-3.69
8.47%-0.54
-68.52%-0.91
-121.03%-0.82
-425.93%-1.42
261.84%2.46
20.27%-0.59
-35.00%-0.54
1,183.33%3.9
-16,087.05%-0.27
Diluted earnings per share
-255.04%-3.69
8.47%-0.54
-68.52%-0.91
-121.75%-0.82
-425.93%-1.42
256.58%2.38
20.27%-0.59
-35.00%-0.54
1,147.22%3.77
-16,087.05%-0.27
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 44.28%190.65M39.49%45.49M50.52%44.8M1.34%37.61M92.17%62.76M52.06%132.14M-5.06%32.61M61.99%29.77M123.48%37.11M85.86%32.66M
Selling and administrative expenses 5.73%42.49M-5.76%10.64M8.88%10.98M-4.50%10.21M31.26%10.66M37.89%40.19M-16.20%11.29M77.10%10.09M121.61%10.7M57.51%8.12M
-General and administrative expense 5.73%42.49M-5.76%10.64M8.88%10.98M-4.50%10.21M31.26%10.66M37.89%40.19M-16.20%11.29M77.10%10.09M121.61%10.7M57.51%8.12M
Research and development costs 61.13%148.16M63.44%34.85M71.85%33.82M3.71%27.39M112.32%52.1M59.21%91.95M2.12%21.32M55.21%19.68M124.24%26.41M97.63%24.54M
Operating profit -44.28%-190.65M-39.49%-45.49M-50.52%-44.8M-1.34%-37.61M-92.17%-62.76M-94.45%-132.14M5.06%-32.61M-61.99%-29.77M-123.48%-37.11M-2,480.25%-32.66M
Net non-operating interest income expense 227.14%21.63M75.89%5.92M149.89%5.88M663.56%5.32M2,188.32%4.51M1,285.95%6.61M2,355.47%3.36M1,894.07%2.35M302.89%697K302.04%197K
Non-operating interest income 227.14%21.63M75.89%5.92M149.89%5.88M663.56%5.32M2,188.32%4.51M1,285.95%6.61M2,355.47%3.36M1,894.07%2.35M302.89%697K302.04%197K
Other net income (expense) -100.07%-201K-139.26%-117K-260K-99.98%69K107K3,460,625.00%276.84M7,350.00%298K3,456,900.00%276.54M
Special income (charges) -100.16%-440K--0---440K--0------276.79M--0--0--276.79M----
-Less:Impairment of capital assets --440K--0--440K----------0--0--0--------
-Gain on sale of business --0--0--0--0------276.79M--0--0--276.79M----
Other non- operating income (expenses) 319.30%239K-139.26%-117K--180K128.63%69K--107K812.50%57K7,350.00%298K-----2,912.50%-241K----
Income before tax -211.83%-169.22M-37.10%-39.69M-42.94%-39.18M-113.41%-32.21M-79.12%-58.14M324.22%151.32M15.38%-28.95M-50.13%-27.41M1,560.76%240.14M-2,387.53%-32.46M
Income tax -133.53%-14.12M-660.06%-14.12M00042.12M-1.86M-2.52M66.07M-19.57M
Net income -242.04%-155.1M5.63%-25.56M-57.42%-39.18M-118.51%-32.21M-350.99%-58.14M261.81%109.2M20.81%-27.09M-36.32%-24.89M1,158.85%174.07M-1,008.53%-12.89M
Net income continuous Operations -242.04%-155.1M5.63%-25.56M-57.42%-39.18M-118.51%-32.21M-350.99%-58.14M261.81%109.2M20.81%-27.09M-36.32%-24.89M1,158.85%174.07M-1,008.53%-12.89M
Minority interest income 3.96%-1.94M-475.16%-1.76M0077.46%-179K-5.43%-2.02M81.91%-306K90.54%-86K-3.74%-833K-153.32%-794K
Net income attributable to the parent company -237.72%-153.16M11.12%-23.8M-57.97%-39.18M-118.42%-32.21M-379.10%-57.96M269.61%111.21M17.63%-26.78M-42.96%-24.8M1,218.56%174.9M-17,182.86%-12.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -237.72%-153.16M11.12%-23.8M-57.97%-39.18M-118.42%-32.21M-379.10%-57.96M269.61%111.21M17.63%-26.78M-42.96%-24.8M1,218.56%174.9M-17,182.86%-12.1M
Basic earnings per share -250.00%-3.698.47%-0.54-68.52%-0.91-121.03%-0.82-425.93%-1.42261.84%2.4620.27%-0.59-35.00%-0.541,183.33%3.9-16,087.05%-0.27
Diluted earnings per share -255.04%-3.698.47%-0.54-68.52%-0.91-121.75%-0.82-425.93%-1.42256.58%2.3820.27%-0.59-35.00%-0.541,147.22%3.77-16,087.05%-0.27
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg